A prospective single arm phase II study of dacarbazine and treosulfan as first-line therapy in metastatic uveal melanoma

Melanoma Research

Volumn 16, Issue 3, 2006, Pages 245-248

  O'Neill, Penny A ^a   Butt, Mohammad ^a   Eswar, Chinnamani V ^a   Gillis, Pat ^a   Marshall, Ernest ^a  

^a CLATTERBRIDGE CENTRE FOR ONCOLOGY   (United Kingdom)

Author keywords

Dacarbazine; Treosulfan; Uveal melanoma

Indexed keywords

DACARBAZINE; DEXAMETHASONE; ONDANSETRON; TREOSULFAN;

ADULT; AGED; ARTICLE; BLOOD TOXICITY; CANCER COMBINATION CHEMOTHERAPY; CHEMOTHERAPY INDUCED EMESIS; CLINICAL ARTICLE; CLINICAL TRIAL; DISEASE COURSE; DRUG DOSE REDUCTION; DRUG TOLERABILITY; FEMALE; HUMAN; LETHARGY; MALE; METASTASIS; NAUSEA; NEUTROPENIA; PATIENT SELECTION; PHASE 2 CLINICAL TRIAL; PRIORITY JOURNAL; SEPSIS; THROMBOCYTE TRANSFUSION; THROMBOCYTOPENIA; TREATMENT RESPONSE; UVEA MELANOMA;

ADULT; AGED; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; BUSULFAN; DACARBAZINE; FEMALE; HUMANS; MALE; MELANOMA; MIDDLE AGED; NEOPLASM METASTASIS; PROSPECTIVE STUDIES; THROMBOCYTOPENIA; UVEAL NEOPLASMS;

EID: 33746111482     PISSN: 09608931     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.cmr.0000205017.38859.07     Document Type: Article

References (17)

1. Shields JA, Shields CL, De Potter P, Singh AD. Diagnosis and treatment of uveal melanoma. Semin Oncol 1996; 23:763-767.
2. Bedikian AY, Legha SS, Mavligit G, Carrasco CH, Khorana S, Plager C, et al. Treatment of uveal melanoma metastatic to the liver: a review of the M.D. Anderson Cancer Center experience and prognostic factors. Cancer 1995; 76:1665-1670.
3. Flaherty LE, Unger JM, Liu PY, Mertens WC, Sondak VK. Metastatic melanoma from intrauveal primary tumors: the Southwest Oncology Group experience in phase II advanced melanoma clinical trials. Am J Clin Oncol 1998; 21:568-572.
4. Neale MH, Myatt NE, Khoury GG, Weaver P, Lamont A, Hungerford JL, et al. Comparison of the ex vivo chemosensitivity of uveal and cutaneous melanoma. Melanoma Res 2001; 11:601-609.
5. Neuber K, Tom Dieck A, Blodorn-Schlicht N, Itschert G, Karnbach C. Treosulfan is an effective alkylating cytostatic for malignant melanoma in vitro and in vivo. Melanoma Res 1999; 9:125-132.
6. Neuber K, Reinhold U, Deutschmann A, Pfohler C, Mohr P, Pichlmeier U, et al. Second-line chemotherapy of metastatic malignant melanoma with intravenous treosulfan: a phase II multicentre trial. Melanoma Res 2003; 13:81-85.
7. Szelenyi H. A phase I trial of gemcitabine and treosulfan to overcome multidrug resistance in patients with advanced solid tumours. Proc ASCO 1999; 18:A880.
8. Schmittel A, Schuster R, Bechrakis NE, Siehl JM, Foerster MH, Thiel E, Keilholz U. A two-cohort phase II clinical trial of gemcitabine plus treosulfan in patients with metastatic uveal melanoma. Melanoma Res 2005; 15:447-451.
9. Eswar CV, Sheddon M, McMurray A, Marshall E. A phase I/II study of treosulfan and dacarbazine in chemonaive patients with malignant melanoma. Br J Cancer 2001; 85:A74.
10. Therasse P, Arbuck SG, Eisenhauer EA, Wanders J, Kaplan RS, Rubinstein L, et al. New guidelines to evaluate the response to treatment in solid tumors. European Organization for Research and Treatment of Cancer, National Cancer Institute of the United States, National Cancer Institute of Canada. J Natl Cancer Inst 2000; 92:205-216.
11. Diener-West M, Reynolds SM, Agugliaro DJ, Caldwell R, Cumming K, Earle JD, et al. Screening for metastasis from choroidal melanoma: The Collaborative Uveal Melanoma Study Group Report 23. J Clin Oncol 2004; 22:2438-2444.
12. Aoyama T, Mastrangelo MJ, Berd D. Protracted survival after resection of metastatic uveal melanoma. Cancer 2000; 89:1561-1568.
13. Feldman ED, Pingpank JF, Alexander HR Jr. Regional treatment options for patients with uveal melanoma metastatic to the liver. Ann Surg Oncol 2004;11:290-297.
14. Mayer A, Neale MH, Cree I, Hall P, Grant J, de Takats PG. Feasibility and clinical application of an ATP-based tumour chemosensitivity assay in patients with metastatic melanoma. Br J Cancer 1999; 80(Suppl 2):65.
15. Eskelin S, Pyrhonen S, Hahka-Kemppinen M, Tuomaala S, Kivela T. A prognostic model and staging for metastatic uveal melanoma. Cancer 2003; 97:465-475.
16. Pfohler C, Cree IA, Ugurel S, Kuwert C, Haass N, Neuber K, et al. Treosulfan and gemcitabine in metastatic uveal melanoma patients: results of a multicenter feasibility study. Anticancer Drugs 2003; 14:337-340.
17. Schmittel A, Scheulen M, Bechrakis N, Strumberg D, Baumgart J, Bornfeld N, Foerster M, et al. Phase II trial of cisplatin, gemcitabine and treosulfan in patients with metastatic uveal melanoma. Melanoma Res 2005; 15:205-207.